REQUEST A DEMO
Total
USD $0.00
Search more companies

S.L.Pharma Holding, S.R.O. (Slovakia)

Main Activities: Administrative Management and General Management Consulting Services
Full name: S.L.Pharma Holding, S.R.O. Profile Updated: October 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

S.L.Pharma Holding, S.R.O. is an enterprise based in Slovakia. Its main office is in Bratislava. The company operates in the Administrative Management and General Management Consulting Services industry. The company was established on April 16, 1993. The total number of employees is currently 2 - 3 (2023). The latest financial highlights indicate a net sales revenue increase of 459.91% in 2023. Its’ total assets recorded a negative growth of 55.82%. The net profit margin of S.L.Pharma Holding, S.R.O. increased by 184.37% in 2023.

Headquarters
Dvo rakovo nabrezie, 7529/4E
Bratislava; Bratislavsky; Postal Code: 81102

Contact Details: Purchase the S.L.Pharma Holding, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the S.L.Pharma Holding, S.R.O. report to view the information.
Outstanding Shares:
Purchase the S.L.Pharma Holding, S.R.O. report to view the information.
Registered Capital:
Purchase the S.L.Pharma Holding, S.R.O. report to view the information.
Incorporation Date:
April 16, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after S.L.Pharma Holding, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
459.91%
Total operating revenue
600.04%
Operating profit (EBIT)
-95.02%
EBITDA
-459.54%
Net Profit (Loss) for the Period
-68.59%
Total assets
-55.82%
Total equity
-17.48%
Operating Profit Margin (ROS)
142.75%
Net Profit Margin
184.37%
Return on Equity (ROE)
-10.81%
Debt to Equity Ratio
-420.26%
Quick Ratio
-1.61%
Cash Ratio
-0.45%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?